|
ARCN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.65179999964427E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6666000000054E-06 |
| Normal-vs-Stage2 |
1.681570E-02 |
| Normal-vs-Stage3 |
2.841900E-03 |
| Normal-vs-Stage4 |
5.411100E-04 |
| Stage1-vs-Stage2 |
9.043000E-01 |
| Stage1-vs-Stage3 |
6.614800E-01 |
| Stage1-vs-Stage4 |
5.076800E-01 |
| Stage2-vs-Stage3 |
8.635600E-01 |
| Stage2-vs-Stage4 |
5.760400E-01 |
| Stage3-vs-Stage4 |
3.813200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.56130000542143E-08 |
| Normal-vs-AfricanAmerican |
5.187200E-01 |
| Normal-vs-Asian |
9.911000E-01 |
| Caucasian-vs-AfricanAmerican |
1.26330000005392E-06 |
| Caucasian-vs-Asian |
1.802380E-01 |
| AfricanAmerican-vs-Asian |
7.929600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.77859999999486E-05 |
| Normal-vs-Female |
1.19309999990769E-07 |
| Male-vs-Female |
9.589800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.485800E-02 |
| Normal-vs-Age(41-60Yrs) |
5.65010000008748E-07 |
| Normal-vs-Age(61-80Yrs) |
3.95950000000589E-05 |
| Normal-vs-Age(81-100Yrs) |
4.725400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.451200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.764400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.248200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.688800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.666190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.951200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.985800E-02 |
| Normal-vs-Grade 2 |
2.67340000026373E-07 |
| Normal-vs-Grade 3 |
4.373100E-04 |
| Normal-vs-Grade 4 |
5.622900E-03 |
| Grade 1-vs-Grade 2 |
5.947200E-01 |
| Grade 1-vs-Grade 3 |
4.329000E-01 |
| Grade 1-vs-Grade 4 |
6.102800E-01 |
| Grade 2-vs-Grade 3 |
2.711600E-01 |
| Grade 2-vs-Grade 4 |
7.767800E-01 |
| Grade 3-vs-Grade 4 |
6.734800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.61488616817951E-12 |
| Normal-vs-ccB subtype |
1.176190E-03 |
| ccA subtype-vs-ccB subtype |
4.435800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78610000001189E-06 |
| Normal-vs-N1 |
1.153960E-01 |
| N0-vs-N1 |
9.627400E-01 |
|
|
